Lineage
LINE
Lineage (LINE) news
Recent news
RBC raises Lineage target price to $48 from $44
AInvest Wire · Aug 17, 2026Lineage Inc: Guidance FY adj EBITDA of $1.26 - $1.29 billion, adj FFO per share of $2.80 to $3.05
AInvest Wire · Aug 5, 2026Lineage sees FY FFO/share as adj $2.80 to $3.05, saw $2.75 to $3
AInvest Wire · Aug 5, 2026Lineage 2Q adj. EBITDA $320.0M est. $297.9M
AInvest Wire · Aug 5, 2026H.C. Wainwright initiates coverage with buy rating and target price $9
H.C. Wainwright has reiterated a Buy rating for Lineage Cell Therapeutics Inc. (NYSE:LCTX) with a target price of $9.00 per share, maintaining its positive outlook on the company’s growth potential. The stock has experienced a 247% return over the past year, currently trading at $1.90 with a market…
AInvest Wire · Jun 8, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.